Role of CD36 in the formation of non-alcoholic fatty liver disease in mice

doi:10.3877/cma.j.issn.2095-3232.2014.02.012

Abstract

Abstract:

Objective

To investigate the role of cluster of differentiation (CD) 36 in the formation of non-alcoholic fatty liver disease (NAFLD) in mice.

Methods

Twenty specific pathogen free healthy male C57BL/6J mice [8 weeks old, average weight: (18.8±2.3)g] were randomly divided into NAFLD group and control group according to the random number table method with 10 mice in each group. Mice in NAFLD group was fed with high-fat diet for 10 weeks, while mice in control group was fed with normal diet for 10 weeks. The mice were sacrificed after the processing, and samples of cardiac blood and liver tissue were collected. The levels of serum alanine transaminase (ALT), total cholesterol (TC) and triglyceride (TG), levels of TC and TG in liver tissue, pathological changes of liver tissue, expression of CD36 protein and content of its messenger ribonucleic acid (mRNA) in liver tissue of 2 groups were observed. Experimental data of 2 groups were compared using t test.

Results

The level of serum ALT was (49±6)U/L in NAFLD group and (45±7)U/L in control group, where no significant difference was obsersed (t=1.70, P>0.05). The levels of serum TC and TG were (4.42±0.09), (0.45±0.04)mmol/L in NAFLD group and (2.42±0.05), (0.32±0.03)mmol/L in control group respectively. The levels of serum TC and TG in NAFLD group were significantly higher than those in control group (t=21.90, 8.22; P<0.05). The levels of TC and TG in liver tissue were (1.18±0.09), (1.75±0.08)mmol/L in NAFLD group and (0.55±0.06), (1.28±0.06)mmol/L in control group respectively. The levels of TC and TG in liver tissue in NAFLD group were significantly higher than those in control group (t=18.42, 14.86; P<0.05). Obviously fatty degeneration and ballooning degeneration were observed in hepatocytes of NAFLD group, while hepatocytes were normal in morphology and size in control group. The expression of CD36 protein in liver tissue in NAFLD group was significantly stronger than that in control group. The content of CD36 mRNA in liver tissue was 2.75±0.26 in NAFLD group and 1.00±0.08 in control group. The content of CD36 mRNA in liver tissue in NAFLD group was significantly higher than that in control group (t=21.16, P<0.05).

Conclusions

CD36 may play a role in the formation of NAFLD in mice. To decrease its expression can be a new target for the prophylaxis and treatment of NAFLD.

Key words: Fatty liver, Mice, Alanine transaminase, Cholesterol, Triglycerides, Antigens,CD36

Xiuqing Wei, Ying Lin, Huixin He, Mengping Jiang, Bin Wu. Role of CD36 in the formation of non-alcoholic fatty liver disease in mice[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(02): 112-116.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2014.02.012

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2014/V03/I02/112

Figures/Tables 2

References 18

[1]	陈规划,汪根树．肝移植受者生存质量:现状、问题与对策[J]．器官移植, 2013, 4(1): 1-5.
[2]	Chabowski A,Żendzian-Piotrowska M,Konstantynowicz K, et al. Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes[J]. Acta Physiol, 2013, 207(2): 346-357.
[3]	Bonen A,Campbell SE,Benton CR, et al. Regulation of fatty acid transport by fatty acid translocase/CD36[J]. Proc Nutr Soc, 2004, 63(2): 245-249.
[4]	Xu S,Jay A,Brunaldi K, et al. CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane[J]. Biochemistry, 2013, 52(41): 7254-7261.
[5]	Abumrad N,Harmon C,Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process[J]. J Lipid Res, 1998, 39(12): 2309-2318.
[6]	Harmon CM,Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids[J]. J Membr Biol, 1993, 133(1): 43-49.
[7]	Krammer J,Digel M,Ehehalt F, et al. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells[J]. Int J Med Sci, 2011, 8(7): 599-614.
[8]	Buqué X,Cano A,Miquilena-Colina ME, et al. High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes[J]. Am J Physiol Endocrinol Metab, 2012, 303(4): E504-E514.
[9]	Petta S,Handberg A,Marchesini G, et al. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C[J]. J Viral Hepat, 2013, 20(3): 174-182.
[10]	García-Monzón C,Lo Iacono O,Crespo J, et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease[J]. Eur J Clin Invest, 2014, 44(1): 65-73.
[11]	Nishikawa S,Sugimoto J,Okada M, et al. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet[J]. Toxicol Pathol, 2012, 40(1): 71-82.
[12]	Satoh H,Ide N,Kagawa Y, et al. Hepatic steatosis with relation to increased expression of peroxisome proliferator-activated receptor-γ in insulin resistant mice[J]. Biol Pharm Bull, 2013, 36(4): 616-623.
[13]	Ma Y,Huang Y,Yan L, et al. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance[J]. Pharm Res, 2013, 30(5): 1447-1457.
[14]	Guo F,Yang X,Li X, et al. Nuciferine prevents hepatic steatosis and injury induced by a high-fat diet in hamsters[J]. PLoS One, 2013, 8(5): e63770.
[15]	Trombetta A,Togliatto G,Rosso A, et al. Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPARγ transcriptional complex[J]. Diabetes, 2013, 62(4): 1245-1257.
[16]	Madonna R,Salerni S,Schiavone D, et al. Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR α/γ activity in microvascular endothelial cells[J]. Thromb Haemost, 2011, 106(3): 500-510.
[17]	Morán-Salvador E,López-Parra M,García-Alonso V, et al. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts[J]. FASEB J, 2011, 25(8): 2538-2550.
[18]	Clugston RD,Yuen JJ,Hu Y, et al. CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[J]. J Lipid Res, 2014, 55(2): 239-246.

Please choose a citation manager

Content to export